These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 28479381)
1. Integrated clinicopathological features and gene microarray analysis of pancreatic neuroendocrine tumors. Zhou H; Chen Q; Tan W; Qiu Z; Li S; Song Y; Gao S Gene; 2017 Aug; 625():72-77. PubMed ID: 28479381 [TBL] [Abstract][Full Text] [Related]
2. Integrative microRNA-mRNA and protein-protein interaction analysis in pancreatic neuroendocrine tumors. Zhou HQ; Chen QC; Qiu ZT; Tan WL; Mo CQ; Gao SW Eur Rev Med Pharmacol Sci; 2016 Jul; 20(13):2842-52. PubMed ID: 27424984 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis. Zhou Z; Liu S; Zhang M; Zhou R; Liu J; Chang Y; Zhao Q Dig Dis Sci; 2017 Oct; 62(10):2790-2800. PubMed ID: 28815403 [TBL] [Abstract][Full Text] [Related]
4. Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping. Xiao Y; Xu G; Cloyd JM; Du S; Mao Y; Pawlik TM J Gastrointest Surg; 2022 Aug; 26(8):1670-1678. PubMed ID: 35508682 [TBL] [Abstract][Full Text] [Related]
5. Loss of DAXX and ATRX are associated with chromosome instability and reduced survival of patients with pancreatic neuroendocrine tumors. Marinoni I; Kurrer AS; Vassella E; Dettmer M; Rudolph T; Banz V; Hunger F; Pasquinelli S; Speel EJ; Perren A Gastroenterology; 2014 Feb; 146(2):453-60.e5. PubMed ID: 24148618 [TBL] [Abstract][Full Text] [Related]
6. Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis. Lu W; Li N; Liao F Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31412643 [TBL] [Abstract][Full Text] [Related]
7. Microarray based analysis of gene expression patterns in pancreatic neuroendocrine tumors. Wang DD; Liu ZW; Han MM; Zhu ZM; Tu YL; Dou CQ; Jin X; Cai SW; Du N Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3367-74. PubMed ID: 26439030 [TBL] [Abstract][Full Text] [Related]
8. Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Duerr EM; Mizukami Y; Ng A; Xavier RJ; Kikuchi H; Deshpande V; Warshaw AL; Glickman J; Kulke MH; Chung DC Endocr Relat Cancer; 2008 Mar; 15(1):243-56. PubMed ID: 18310291 [TBL] [Abstract][Full Text] [Related]
9. Mammalian target of rapamycin signaling activation patterns in pancreatic neuroendocrine tumors. Komori Y; Yada K; Ohta M; Uchida H; Iwashita Y; Fukuzawa K; Kashima K; Yokoyama S; Inomata M; Kitano S J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):288-95. PubMed ID: 24002888 [TBL] [Abstract][Full Text] [Related]
10. Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors. Scott AT; Weitz M; Breheny PJ; Ear PH; Darbro B; Brown BJ; Braun TA; Li G; Umesalma S; Kaemmer CA; Maharjan CK; Quelle DE; Bellizzi AM; Chandrasekharan C; Dillon JS; O'Dorisio TM; Howe JR Clin Cancer Res; 2020 Apr; 26(8):2011-2021. PubMed ID: 31937620 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing. Wong HL; Yang KC; Shen Y; Zhao EY; Loree JM; Kennecke HF; Kalloger SE; Karasinska JM; Lim HJ; Mungall AJ; Feng X; Davies JM; Schrader K; Zhou C; Karsan A; Jones SJM; Laskin J; Marra MA; Schaeffer DF; Gorski SM; Renouf DJ Cold Spring Harb Mol Case Stud; 2018 Feb; 4(1):. PubMed ID: 29092957 [TBL] [Abstract][Full Text] [Related]
12. Expression profiling of small intestinal neuroendocrine tumors identified pathways and gene networks linked to tumorigenesis and metastasis. Wang Q; Yu C Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32496505 [TBL] [Abstract][Full Text] [Related]
13. Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors. Meng D; Zhao L; Liu J; Ge C; Zhang C Neuroendocrinology; 2023; 113(7):719-735. PubMed ID: 36871552 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic regulation of the lncRNA MEG3 and its target c-MET in pancreatic neuroendocrine tumors. Modali SD; Parekh VI; Kebebew E; Agarwal SK Mol Endocrinol; 2015 Feb; 29(2):224-37. PubMed ID: 25565142 [TBL] [Abstract][Full Text] [Related]
15. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149 [TBL] [Abstract][Full Text] [Related]